HANDAYANI, FITRI, et al. “IMPACT OF THE COMBINATION OF DOXORUBICIN, CYCLOPHOSPHAMIDE, AND DOCETAXEL ON CA 15-3 BIOMARKER LEVELS IN BREAST CANCER PATIENTS: A COMPARATIVE STUDY BETWEEN DELAYED AND NON-DELAYED CHEMOTHERAPY”. International Journal of Applied Pharmaceutics, vol. 17, no. 1, Feb. 2025, pp. 82-88, doi:10.22159/ijap.2025.v17s1.12.